The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

  • A Mocroft
  • H J Furrer
  • J M Miro
  • P Reiss
  • C Mussini
  • Kirk, Ole
  • S Abgrall
  • S Ayayi
  • B Bartmeyer
  • D Braun
  • A Castagna
  • A d'Arminio Monforte
  • B Gazzard
  • F Gutierrez
  • I Hurtado
  • Karina Jansen
  • L Meyer
  • P Muñoz
  • Obel, Niels
  • P Soler-Palacin
  • A Papadopoulos
  • F Raffi
  • J T Ramos
  • J K Rockstroh
  • D Salmon
  • C Torti
  • J Warszawski
  • S de Wit
  • R Zangerle
  • C Fabre-Colin
  • J Kjaer
  • G Chene
  • J Grarup
  • Lundgren, Jens
  • Opportunistic Infections Working Group on behalf of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCOORD
Few studies consider the incidence of individual AIDS-defining illnesses (ADIs) at higher CD4 counts, relevant on a population level for monitoring and resource allocation.
OriginalsprogEngelsk
TidsskriftClinical infectious diseases : an official publication of the Infectious Diseases Society of America
Vol/bind57
Udgave nummer7
Sider (fra-til)1038-47
Antal sider10
DOI
StatusUdgivet - okt. 2013

ID: 105606216